Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolates

Journal of Clinical Microbiology

Volumn 45, Issue 5, 2007, Pages 1556-1560

  Ledeboer, Nathan A ^a   Das, Kingshuk ^a   Eveland, Michael ^b   Roger Dalbert, Céline ^c   Mailler, Sandrine ^c   Chatellier, Sonia ^c   Dunne, William Michael ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZIDE; CHROMOGENIC SUBSTRATE; ESCULIN; VANCOMYCIN;

AGAR MEDIUM; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EVALUATION; FECES ANALYSIS; HUMAN; HUMAN TISSUE; INCUBATION TIME; INFECTION CONTROL; MAJOR CLINICAL STUDY; PREDICTION AND FORECASTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AGAR; BACTERIAL TYPING TECHNIQUES; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FECES; HUMANS; SENSITIVITY AND SPECIFICITY; VANCOMYCIN RESISTANCE;

ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM;

EID: 34248595510     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02116-06     Document Type: Article

References (19)

1. Reference deleted.
2. Bhavnani, S. M., J. A. Drake, A. Forrest, J. A. Deinhart, R. N. Jones, D. J. Biedenbach, and C. H. Ballow. 2000. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn. Microbiol. Infect. Dis. 36:145-158.
3. Carmeli, Y., G. Eliopoulos, E. Mozaffari, and M. Samore. 2002. Health and economic outcomes of vancomycin-resistant enterococci. Arch. Intern. Med. 28:2223-2228.
4. Centers for Disease Control and Prevention. 1995. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am. J. Infect. Control. 23:87-94.
5. Centers for Disease Control and Prevention. 1999. National nosocomial infections surveillance (NNIS) system report, data summary from January 1990 to May 1999. Am. J. Infect. Control. 27:520-532.
6. Courvalin, P. 2005. Genetics of glycopeptide resistance in gram-positive pathogens. Int. J. Med. Microbiol. 294:479-486.
7. Depardieu, F., B. Perichon, and P. Courvalin. 2004. Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. J. Clin. Microbiol. 42:5857-5860.
8. Garbutt, J. M., M. Ventrapragada, B. Littenberg, and L. M. Mundy. 2000. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin. Infect. Dis. 30:466-472.
9. Lautenbach, E., W. B. Bilker, and P. J. Brennan. 1999. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect. Control Hosp. Epidemiol. 20:318-323.
10. Leclercq, R., E. Derlot, J. Duval, and P. Courvalin. 1988. Plasmid-mediated resistance to vancomycin and teicoplanm in Enterococcus faecium. N. Engl. J. Med. 319:157-161.
11. Moellering, R. C. 1992. Emergence of Enterococcus as a significant pathogen. Qin. Infect. Dis. 14:1173-1178.
12. Moellering, R. C. 2005. Enterococcus species, Streptococcus bovis, and Leuconostoc species, p. 2411-2421. In G. L Mandell, J. R. Bennett, and R. Dolin, Principles and practices of infectious diseases, 6th ed., vol 2. Elsevier Churchill Livingstone, Philadelphia, PA.
13. Poyart, C., G. Quesne, C. Boumaila, and P. Trieu-Cuot. 2001. Rapid and accurate species-level identification of coagulase-negative staphylococci by using the sodA gene as a target. J. Clin. Microbiol. 39:4296-4301.
14. Sloan, L. M., J. R. Uhl, E. A. Vetter, C. D. Schleck, W. S. Harmsen, J. Manahan, R. L. Thompson, J. E. Rosenblatt, and F. R. Cockerill III. 2004. Comparison of the Roche LightCycler vanA/vanB detection assay and culture for detection of vancomycin-resistant enterococci from perianal swabs. J. Clin. Microbiol. 42:2636-2643.
15. Song, X., A. Srinivasan, D. Plaut, and T. M. Perl. 2003. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect. Control Hosp. Epidemiol. 24:251-256.
16. Stosor, V., L. R. Peterson, M. Postelnick, and G. A. Noskin. 1998. Enterococcus faecium bacteremia. Does vancomycin resistance make a difference? Arch. Intern. Med. 158:522-527.
17. Teixeira, L. M., and R. M. Facklam. 2003. Enterococcus, p. 422-433. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed., vol 1. ASM Press, Washington, DC.
18. Uttley, A. H. C., C. H. Collins, J. Naidoo, and R. C. George. 1988. Vancomycin-resistant enterococci. Lancet i:57-58.
19. Webb, M., L. W. Riley, and R. B. Roberts. 2001. Cost of hospitalisation for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization. Clin. Infect. Dis. 33:445-452.